Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H

Abstract

Aromatase (CYP19A1) converts androgens into estrogens and is required for female sexual development and growth and development in both sexes. CYP19A1 is a member of cytochrome P450 family of heme-thiolate monooxygenases located in the endoplasmic reticulum and depends on reducing equivalents from the reduced nicotinamide adenine dinucleotide phosphate via the cytochrome P450 oxidoreductase coded by POR. Both the CYP19A1 and POR genes are highly polymorphic, and mutations in both these genes are linked to disorders of steroid biosynthesis. We have previously shown that R264C and R264H mutations in CYP19A1, as well as mutations in POR, result in a reduction of CYP19A1 activity. The R264C is a common polymorphic variant of CYP19A1, with high frequency in Asian and African populations. Polymorphic alleles of POR are found in all populations studied so far and, therefore, may influence activities of CYP19A1 allelic variants. So far, effects of variations in POR on enzymatic activities of allelic variants of CYP19A1 or any other steroid metabolizing cytochrome P450 proteins have not been studied. Here we are reporting the effects of three POR variants on the aromatase activities of two CYP19A1 variants, R264C and R264H. We used bacterially expressed and purified preparations of WT and variant forms of CYP19A1 and POR and constructed liposomes with embedded CYP19A1 and POR proteins and assayed the CYP19A1 activities using radiolabeled androstenedione as a substrate. With the WT-POR as a redox partner, the R264C-CYP19A1 showed only 15% of aromatase activity, but the R264H had 87% of aromatase activity compared to WT-CYP19A1. With P284L-POR as a redox partner, R264C-CYP19A1 lost all activity but retained 6.7% of activity when P284T-POR was used as a redox partner. The R264H-CYP19A1 showed low activities with both the POR-P284L as well as the POR-P284T. When the POR-Y607C was used as a redox partner, the R264C-CYP19A1 retained around 5% of CYP19A1 activity. Remarkably, The R264H-CYP19A1 had more than three-fold higher activity compared to WT-CYP19A1 when the POR-Y607C was used as the redox partner, pointing towards a beneficial effect. The slight increase in activity of R264C-CYP19A1 with the P284T-POR and the three-fold increase in activity of the R264H-CYP19A1 with the Y607C-POR point towards a conformational effect and role of protein-protein interaction governed by the R264C and R264H substitutions in the CYP19A1 as well as P284L, P284T and Y607C variants of POR. These studies demonstrate that the allelic variants of P450 when present with a variant form of POR may show different activities, and combined effects of variations in both the P450 enzymes as well as in the POR should be considered when genetic data are available. Recent trends in the whole-exome and whole-genome sequencing as diagnostic tools will permit combined evaluation of variations in multiple genes that are interdependent and may guide treatment options by adjusting therapeutic interventions based on laboratory analysis. Keywords: CYP19A1; Aromatase;...

Computational systems pharmacology analysis of Tong-Jing-Yi formula in the treatment of dysmenorrhea

“…The CYP19A1 gene encodes an aromatase that catalyzes the conversion of testosterone and androstenedione to estrone and estradiol. Aromatase, also known as estrogen synthase, is expressed in endometrial cancer, breast cancer, endometriosis and uterine leiomyoma, and its overexpression is related to the occurrence and development of these diseases [27]. Among the top 15 targets, PIK3CA, AKT1, EGFR and AKT2 were reported to be related to inflammation.…”

Molecular Basis for Endocrine Disruption by Pesticides Targeting Aromatase and Estrogen Receptor

“…The increase obtained in the aromatase activity in the presence of imidacloprid and thiacloprid, even if not statistically significant, can be interesting to be further investigated. Indeed, these two compounds could directly act on aromatase as allosteric activators or they could exert their action indirectly on CPR that has an essential role in catalysis and acts as an effector on human aromatase conformation [ 80 , 81 ].…”

Loss of protein stability and function caused by P228L variation in NADPH-cytochrome P450 reductase linked to lower testosterone levels

“…Henceforth, our group started to study how these common variants could affect the healthy carriers without an evident phenotype, especially at the level of drug metabolism. Previous studies of our group have shown that polymorphisms in POR can alter the enzymatic activities of its redox partners [6,[17][18][19][20][21].…”

“…Activities of CYP17A1 and CYP19A1 were measure with WT or P228L variant of POR using methods described in detail in our previous publications [14, 18, 20, 21, 30, 40, 44, 45].…”